Medical technology company Medtronic has increased the production of ventilators by more than 40% due to the global coronavirus (Covid-19) outbreak and to cater to the increase of demands of patients and healthcare systems across the world.
The company has more than 250 employees who manufacture ventilators in its Ireland facility.
Medtronic has also put in place extra manufacturing shifts and is introducing new shift patterns to bring the plant to 24/7 operation.
Ventilators play a critical role in the management of patients with a severe respiratory illness such as Covid-19. They allow patients who cannot breath effectively to rest and recover while supplying oxygen and simulating breathing.
Medtronic Minimally Invasive Therapies Group president and executive vice-president Bob White said: “Medtronic recognises the demand for ventilators in this environment has far outstripped supply. No single company will be able to fill the current demands of global healthcare systems.
“However, with all manufacturers increasing their production and through partnerships with governments, hospitals and global health organisations, Medtronic is committed to getting more ventilators into the market and to the right locations in the world to help doctors and patients dealing with Covid-19.”
The company produces high-performance ventilators for various care settings, including the acute sub-acute segments.
They include Puritan Bennett 980 (PB 980) and Puritan Bennett 840 (PB 840) that are manufactured in Galway, Ireland, and are designed for critically ill patients in high acuity setting.
Ventilator demand has significantly increased due to the coronavirus infection, which causes severe respiratory illness in patients and other symptoms such as fever and cough.